MBX Biosciences | SC 13G:超过5%持股股东披露文件-Wellington Management Group LLP(9.22%),Wellington Group Holdings LLP(9.22%)等
MBX Biosciences | 10-Q:季度报表
MBX Biosciences | 8-K:MBX Biosciences公布2024年第三季度财务业绩并提供业务最新情况
MBX Biosciences | SC 13G:超过5%持股股东披露文件-P. Kent Hawryluk(5.55%)
MBX Biosciences | SC 13D:超过5%持股股东披露文件-Norwest Venture Partners XVI, LP(6.4%),Genesis VC Partners XVI, LLC(6.4%)等
MBX Biosciences | SC 13D:超过5%持股股东披露文件-New Enterprise Associates 17, L.P.(11.4%),NEA Partners 17, L.P.(11.4%)等
MBX Biosciences | SC 13D:超过5%持股股东披露文件-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%)等
MBX Biosciences | SC 13G:超过5%持股股东披露文件-Deep Track Capital, LP(9.48%),Deep Track Biotechnology Master Fund, Ltd.(9.48%)等
MBX Biosciences | SC 13D:超过5%持股股东披露文件-James N. Topper(18.8%),Patrick J. Heron(18.8%)等
MBX Biosciences | SC 13G:超过5%持股股东披露文件-Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.(5.62%)
MBX Biosciences | 4:持股变动声明-董事 Mathers Edward T
MBX Biosciences | 4:持股变动声明-股东 BASKETT FOREST
MBX Biosciences | 4:持股变动声明-股东 Behbahani Ali
MBX Biosciences | 4:持股变动声明-股东 Chang Carmen
MBX Biosciences | 4:持股变动声明-股东 Florence Anthony A. Jr.
MBX Biosciences | 4:持股变动声明-股东 Makhzoumi Mohamad
MBX Biosciences | 4:持股变动声明-股东 Walker Paul Edward
MBX Biosciences | 4:持股变动声明-股东 Yang Rick
MBX Biosciences | 4:持股变动声明-股东 SANDELL SCOTT D
MBX Biosciences | 4:持股变动声明-董事 ORBIMED ADVISORS LLC
暂无数据
暂无数据